Daniel Barocas

Daniel Barocas, MD, MPH, FACS is a Professor in the Department of Urology at Vanderbilt University Medical Center, where he also serves as Executive Vice Chair. He specializes in Urologic Oncology, with clinical focus on prostate, kidney, and bladder cancers, and expertise in laparoscopic and robotic surgery.

His research is centered on improving patient outcomes through studies on quality of life, quality of care, and comparative effectiveness in urologic oncology. He leads a multi-center study evaluating treatment effectiveness and side effects in prostate cancer and is the Principal Investigator for the NCI Early Detection Research Network (EDRN) Prostate MRI Biomarker Study.

Dr. Barocas completed his medical degree at Johns Hopkins University School of Medicine, residency at New York Presbyterian Hospital-Weill Cornell Medical Center, and fellowship at Vanderbilt University Medical Center. He is a Fellow of the American College of Surgeons (FACS).

His work spans translational research, health services, and clinical trials, particularly in prostate cancer diagnostics and treatment evaluation. Current research emphasizes imaging biomarkers and long-term patient-reported outcomes.

• Principal Investigator, Multi-Center Prostate Cancer Treatment Study
• Principal Investigator, NCI EDRN Prostate MRI Biomarker Study

Dr. Barocas is actively engaged in clinical innovation and research leadership within the Division of Urologic Oncology and contributes to training through medical education and fellowship programs at Vanderbilt.